MAHE and Novo Nordisk GBS expand collaboration in pharmacometrics
Novo Nordisk GBS will provide financial support of ₹1.75 crore over five years to enhance specialised talent development, research capacity and advanced infrastructure in quantitative drug development.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)